Table 2 Subtypes of irAEs in the study population n (%)
Subtypes of irAEs | Total | Grade | ||
|---|---|---|---|---|
1 | 2 | 3 | ||
irAEs | 27(24.11%) | 12(44.40%) | 10(37.04%) | 6(22.22%) |
Adverse skin reaction | 8(29.6%) | 3(37.50%) | 3(37.50%) | 2(25.00%) |
Adverse endocrine reaction | 7(25.9%) | 3(42.90%) | 2(28.60%) | 2(28.60%) |
Gastrointestinal adverse reactions | 3(11.1%) | 2(66.70%) | 1(33.30%) | 0(0.00%) |
Hematology adverse reaction | 1(3.7%) | 0(0.00%) | 1(100.00%) | 0(0.00%) |
Immune associated pneumonia | 5(18.5%) | 1(20.00%) | 2(40.00%) | 2(40.00%) |
Immune - related liver injury | 2(7.5%) | 1(50.00%) | 1(50.00%) | 0(0.00%) |
Others | 1(3.7%) | 1(100%) | 0(0.00%) | 0(0.00%) |